Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We tested its activity in comparison with four other quinolones and isoniazid against clinical isolates of mycobacteria. It proved to be the most active of the quinolones tested against Mycobacterium tuberculosis (MIC90 0.25 mg/L), Mycobacterium avium-intracellulare (MIC90 1.0 mg/L), Mycobacterium kansasii (MIC90 0.06 mg/L) and Mycobacterium fortuitum (MIC90 1 mg/L). These data indicate that moxifloxacin merits further study as an antimycobacterial agent.</p
The relationship between the structures of quinolones and their anti-Mycobacterium avium activities ...
Current treatment for tuberculosis (TB) is complicated by the emergence of multidrug resistant TB (M...
Background: In vitro and animal studies have shown that moxifloxacin-containing combinations may imp...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
The activity of moxifloxacin was enhanced by the addition of ethionamide but not by that of cycloser...
Moxifloxacin is the most active fluoroquinolone against Mycobacterium tuberculosis in vitro. However...
textabstractA number of antimycobacterial agents were evaluated with respect to their bacteriostatic...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
the bactericidal activity of moxifloxacin, alone and in combination with isoniazid and rifampin, wa...
ObjectiveTo evaluate the in vitro antibacterial activity of moxifloxacinin in comparison to that of ...
Moxifloxacin (CAS 186286-86-8) is a recent fluoroquinolone addressed to the treatment of respiratory...
The susceptibility of 11 clinical isolates of Mycobacterium tuberculosis, 3 M. kansasii,3 M. xenopi,...
Patients in whom acid-fast bacilli smear-positive pulmonary tuberculosis was newly diagnosed were ra...
Patients in whom acid-fast bacilli smear-positive pulmonary tuberculosis was newly diagnosed were ra...
The relationship between the structures of quinolones and their anti-Mycobacterium avium activities ...
Current treatment for tuberculosis (TB) is complicated by the emergence of multidrug resistant TB (M...
Background: In vitro and animal studies have shown that moxifloxacin-containing combinations may imp...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
The activity of moxifloxacin was enhanced by the addition of ethionamide but not by that of cycloser...
Moxifloxacin is the most active fluoroquinolone against Mycobacterium tuberculosis in vitro. However...
textabstractA number of antimycobacterial agents were evaluated with respect to their bacteriostatic...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
the bactericidal activity of moxifloxacin, alone and in combination with isoniazid and rifampin, wa...
ObjectiveTo evaluate the in vitro antibacterial activity of moxifloxacinin in comparison to that of ...
Moxifloxacin (CAS 186286-86-8) is a recent fluoroquinolone addressed to the treatment of respiratory...
The susceptibility of 11 clinical isolates of Mycobacterium tuberculosis, 3 M. kansasii,3 M. xenopi,...
Patients in whom acid-fast bacilli smear-positive pulmonary tuberculosis was newly diagnosed were ra...
Patients in whom acid-fast bacilli smear-positive pulmonary tuberculosis was newly diagnosed were ra...
The relationship between the structures of quinolones and their anti-Mycobacterium avium activities ...
Current treatment for tuberculosis (TB) is complicated by the emergence of multidrug resistant TB (M...
Background: In vitro and animal studies have shown that moxifloxacin-containing combinations may imp...